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Abstract 
Background: Pediatric oncology patients often experience nutritional status changes, 
particularly malnutrition, which may adversely affect their outcomes.  Although the 
consequences of malnutrition are elucidated, its causes remain unclear.  A possible 
cause of malnutrition in pediatric oncology patients is repetitive, pre-anesthetic fasting 
prior to non-invasive procedures and treatments, such as anesthesia-assisted radiation 
therapy (AART).  This exploratory study investigated the association between repetitive, 
pre-anesthetic fasting and non-fasting days and malnutrition in pediatric oncology 
patients receiving AART.    
Procedure: A retrospective cohort of 138 pediatric oncology patients ( 10 years of age) 
who received any type of radiation therapy (RT) with or without anesthesia between 
2006 and 2015 in a tertiary care hospital was evaluated for nutritional status changes 
from the start to the end of RT using three primary indicators for malnutrition (weight 
gain velocity < 75% of expected weight gain, deceleration in weight for length/height z-
score  1, and percent weight loss  5%).  Univariate and multivariate regression 
analyses were conducted to evaluate the association between fasting and non-fasting 
days and malnutrition.  
Results: The number of fasting and non-fasting days was not significantly associated 
with malnutrition by the end of AART. However, after adjusting for age, patients who 
received concurrent chemotherapy had higher odds of becoming malnourished (odds 
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ratio [OR] = 3.48; p = 0.024).  Furthermore, after adjusting for concurrent chemotherapy, 
patients 2 years of age and older had lower odds of becoming malnourished (OR = 0.23, 
p = 0.018 for patients  2 to < 5 years; OR = 0.26, p = 0.047 for patients  5 years). 
Conclusions: In pediatric oncology patients receiving AART, malnutrition status is not 
associated with repetitive, pre-anesthetic fasting, but with young age and concurrent 
chemotherapy.  Further research is needed to corroborate these findings. 
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Summary of Study 
 
The primary goal of this research study was to investigate the malnutrition status of 
pediatric oncology patients undergoing anesthesia-assisted radiation therapy, which 
requires intermittent repetitive fasting.  The completed study summarized in the 
manuscript did not include or analyzed several of the outcome measures originally 
outlined in the research proposal, which included the following: 
1. Deceleration in weight for length/height z-scores for all children were not 
obtained. Z-score tables for this primary indicator were only available for 
lengths/heights < 121.5 cm. 
2. Cancer grade and stage, secondary diagnoses, chemotherapy treatment, and 
protocol information was not available for significant number of included cases, 
therefore it was unable to be analyzed. 
3. No documented diagnosis of nutritional deficiencies based on ICD-9 codes 
during radiation therapy dates were found. 
4. Data for discharge time of recovery unit after each anesthetic administration after 
radiation therapy was not available during chart review, therefore these data 
were not abstracted. 
5. Start and end of anesthesia, cumulative intravenous fluid administration, lab 
values, and radiation type and site were not analyzed because of significant 
missing values or disparity in data abstracted (for example, lab values available 
or disparity in timing during radiation therapy).  
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Research Proposal 
 
A. Specific Aims 
 
Approximately 43% of children in the US are chronically ill.(Bethell et al., 2011) One 
chronic illness is cancer, which is the leading cause of death by disease in children after 
infancy. In the US, 1 in 285 children is diagnosed with cancer before 20 years of 
age.(American Cancer Society, 2014) Pediatric oncology patients undergo multiple 
diagnostic and therapeutic procedures that require anesthesia during their course of 
illness, often to ensure immobility during non-invasive procedures.(Latham, 2014) This is 
the case for pediatric oncology patients under 10 years of age receiving radiation 
therapy, who require daily anesthesia for up to 6 consecutive weeks.(Buchsbaum et al., 
2013; McFadyen, Pelly, & Orr, 2011; Scheiber, Ribeiro, Karpienski, & Strehl, 1996) 
These children undergo pre-anesthetic fasting prior to each administration of 
anesthesia,(American Society of Anesthesiologists Committee, 2011) which may place 
them at risk for malnutrition. Malnutrition in pediatric oncology patients has been 
associated with poor clinical outcomes including a higher incidence of treatment-related 
mortality.(Antillon et al., 2013; Brinksma et al., 2015; Ethier et al., 2012; Inaba et al., 
2012; Loeffen, Brinksma, Miedema, de Bock, & Tissing, 2015; Orgel et al., 2014; Sala et 
al., 2012) However, the association between repetitive pre-anesthetic fasting and 
malnutrition in pediatric oncology patients has not been investigated. This gap in 
knowledge poses a substantial problem in this population because healthcare providers 
are unable to assess the potential effect of repetitive pre-anesthetic fasting on patients’ 
nutritional status. 
Our long-term goal is to identify factors that place chronically ill pediatric patients at risk 
for worse outcomes and to develop interventions to improve outcomes. The overall 
objective of this exploratory study, which is the first step in pursuit of our goal, is to 
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determine the association between repetitive pre-anesthetic fasting and malnutrition in a 
population of pediatric oncology patients who received anesthesia-assisted radiation 
therapy (AART) for up to 6 weeks. Our central hypothesis is that repetitive pre-
anesthetic fasting negatively affects the nutritional status of pediatric patients. Our 
hypothesis is formulated on the basis that the nutritional requirements of chronically ill 
children are frequently unmet,(Groleau et al., 2014; Hendricks et al., 1995; Huysentruyt 
et al., 2013; Joosten & Hulst, 2008; Mara et al., 2014; Silva et al., 2013) and that fasting 
creates various adverse metabolic effects (e.g., depletion of hepatic glycogen reserves, 
increased protein catabolism, higher energy expenditure at rest).(Awad, Constantin-
Teodosiu, Macdonald, & Lobo, 2009; Awad & Lobo, 2012; Nygren, 2006) The rationale 
for the proposed research is that establishing the association between repetitive fasting 
and nutritional status in this population will enable the study of the underlying metabolic 
mechanisms of repetitive pre-anesthetic fasting on nutritional status (e.g., post-treatment 
insulin resistance) and subsequent long-term outcomes (e.g., treatment response, 
event-free survival rate). We expect this to result in the development of new 
interventions to improve outcomes in chronically ill pediatric patients.  
We plan to test our central hypothesis with the following two specific aims: 
1. Determine the association between total pre-anesthetic fasting days and 
primary indicators for nutritional status (weight gain velocity in patients  
24 months age; weight loss in patients   24 months age; deceleration in 
weight for length/height z-scores in all patients) in pediatric patients under 
10 years of age during a radiation therapy (RT) cycle. We hypothesize that a 
higher number of pre-anesthetic fasting days during an RT cycle will be 
associated with worse nutritional status.  
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2. Determine the association between total non-fasting days (i.e., treatment 
off days during AART or treatment days without AART) and primary 
indicators for nutritional status in pediatric patients under 10 years of age 
during a RT cycle. We anticipate, based on our hypothesis, that a higher 
number of non-fasting days during an RT cycle will be associated with better 
nutritional status.  
    
With respect to outcomes, we expect to determine the associations between repetitive 
pre-anesthetic fasting and nutritional status changes in pediatric patients over a 
specified treatment period. The findings are anticipated to advance the fields of pediatric 
anesthesia, clinical nutrition, and radiation oncology by identifying modifiable factors that 
will inform the development of new interventions for nutritional pre-anesthetic evaluation, 
management, and follow-up. Additionally, these findings are anticipated to have a 
positive translational impact because the determined associations will provide the 
preliminary data to support the study of various nutrition-related long-term outcomes, 
which are discussed in the Significance section.  
 
B. Research Strategy  
Significance 
Current practice guidelines for pre-anesthetic fasting recommend that children abstain, 
at minimum, from breast milk for 4 hours, from clear liquids for 2 hours, and from 
nonhuman milk or solid foods for 6 hours prior to anesthesia.(American Society of 
Anesthesiologists Committee, 2011) In actual practice, anesthetic providers use their 
clinical judgment to determine the appropriate minimum fasting time prior to each 
anesthetic administration; therefore, reported pre-anesthetic fasting times are usually 
much longer than the minimum recommendations. (Arun & Korula, 2013a; Hancock, 
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Cresci, & Martindale, 2002; Williams et al., 2014) It is important to note that parent-
reported pre-anesthetic fasting times may not be accurate in some cases.(Adudu, 
Egwakhide, & Adudu, 2008; Cantellow, Lightfoot, Bould, & Beringer, 2012; Kushnir, 
Djerassi, Sofer, & Kushnir, 2015) Despite the varying length of time that children fast 
prior to each anesthetic, repetitive pre-anesthetic fasting may place pediatric patients at 
risk for malnutrition. Malnutrition in pediatric oncology patients has been associated with 
worse health-related quality of life, increased occurrences of febrile neutropenia, higher 
incidence of treatment-related mortality, and lower event-free survival rates. (Antillon et 
al., 2013; Brinksma et al., 2015; Ethier et al., 2012; Inaba et al., 2012; Loeffen et al., 
2015; Orgel et al., 2014; Sala et al., 2012) However, it is unknown whether repetitive 
pre-anesthetic fasting is associated with nutritional status in these patients. Our 
expected contribution is to determine the extent to which repetitive pre-anesthetic fasting 
is associated with malnutrition. This contribution is significant because it will provide a 
positive translational impact on the assessment and improvement of long-term clinical 
outcomes in chronically ill pediatric patients. Specifically, interventions to improve 
nutritional outcomes based on identified risk factors can be developed and tested. For 
example, pediatric anesthetists will have empirical evidence to develop new protocols to 
evaluate nutritional status during their pre-anesthetic assessment in order to identify 
patients at high risk for malnutrition, who should be referred to clinical nutritionists.  
Clinical nutritionists could then develop individualized diet plans, while radiation 
oncologists could consider modifying treatment cycle schedules for high-risk patients to 
minimize the amount or length of time of pre-anesthetic fasting. Thus, important 
advances in clinical practice and multidisciplinary collaboration are expected. It is also 
expected that this exploratory study will provide the basis for investigating the 
relationship between repetitive pre-anesthetic fasting and malnutrition with subsequent 
long-term outcomes, such as treatment-related toxicity, quality of life, and event-free 
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survival, in order to improve overall outcomes. Furthermore, this exploratory study is 
significant because it will contribute to the broader understanding of iatrogenic-related 
clinical malnutrition.  
Innovation  
To date, most research in the area of pre-anesthetic fasting in pediatric patients has 
been limited to single instances of fasting and has focused on the prevention of 
pulmonary aspiration,(Andersson, Zaren, & Frykholm, 2015; Arun & Korula, 2013b; 
Brady, Kinn, O'Rourke, Randhawa, & Stuart, 2005; Buehrer et al., 2014; Campbell, 
2011; Castillo-Zamora, Castillo-Peralta, & Nava-Ocampo, 2005; Chen, Toung, Haupt, 
Hutchins, & Cameron, 1984; Engelhardt, 2015; Gombar, Dureja, Kiran, Gombar, & 
Chhabra, 1997; Goudsouzian & Young, 1987; Henderson, Spence, Clarke, Bonn, & 
Noel, 1987; Jabbari Moghaddam, Seyedhejazi, Naderpour, Yaghooblua, & Golzari, 
2014; D. A. Kelly, 1994; Kemmotsu et al., 1991; Kraus, Braun, Gotz, Raithel, & Danner, 
1990; Luce et al., 2014; Maekawa, Mikawa, Yaku, Nishina, & Obara, 1993a; Maekawa, 
Nishina, Mikawa, Shiga, & Obara, 1998; Muhammad, Wadood, Haroon, Khan, & Shah, 
2012; Patino et al., 2015; Poulton, 2012; Schmidt et al., 2015; Schmitz et al., 2011; 
Schmitz, Kellenberger, Liamlahi, Studhalter, & Weiss, 2011; Schmitz et al., 2012; 
Scrimgeour, Leather, Perry, Pappachan, & Baldock, 2015) management of intravenous 
fluids,(Gawecka & Mierzewska-Schmidt, 2014a; Hashimoto, Fujii, & Serada, 2011; Murat 
& Dubois, 2008; Sumiyoshi, 2013) evaluation of complications,(Andersson et al., 2015; 
C. J. Kelly & Walker, 2015; Ribeiro de Amorim et al., 2015; Robertson-Malt et al., 2008; 
Scarlett, Crawford-Sykes, & Nelson, 2002) and assessment of immediate short-term 
outcomes.(Klemetti et al., 2010; Yurtcu, Gunel, Sahin, & Sivrikaya, 2009) In the relatively 
few studies that have focused on pediatric nutritional outcomes, researchers 
investigated the tolerance of carbohydrate oral solutions preoperatively or depletion of 
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blood glucose postoperatively.(Adenekan, 2014; Gawecka & Mierzewska-Schmidt, 
2014b; Huang et al., 1993; Jensen, Wernberg, & Andersen, 1982; Maekawa, Mikawa, 
Yaku, Nishina, & Obara, 1993b; Shah, Zahoorullah, Haq, & Akhtar, 1990; 
Somboonviboon & Kijmahatrakul, 1996) The proposed research is innovative, in our 
opinion, because it represents a fundamental and significant departure from the status 
quo by shifting the focus from single instances of pre-anesthetic fasting to repetitive 
instances, and because it evaluates nutritional status changes as an outcome for the 
first time. We expect that results from this exploratory study will open new avenues in 
pediatric research by providing the preliminary data to support future research on the 
underlying metabolic and nutritional effects associated with repetitive pre-anesthetic 
fasting and their subsequent long-term outcomes. For example, research investigating 
the benefits of caloric restriction in reducing oxidative stress and improving cancer 
treatment responses is emerging.(Champ et al., 2013; Dan, Wright, & Simone, 2014; 
Habermann et al., 2015; Jin et al., 2014; Klement, 2013; Klement & Champ, 2014; 
Kowaltowski, 2011; Oliai & Yang, 2014; Saleh et al., 2013; Seyfried, Flores, Poff, 
D'Agostino, & Mukherjee, 2015; Simone et al., 2013; Yoshida, Hirabayashi, Watanabe, 
Sado, & Inoue, 2006) In addition, the associations between the metabolic responses 
from a single episode of pre-anesthetic fasting with baseline characteristics (e.g., 
malnutrition preoperatively) and postoperative outcomes (e.g., length of stay) have 
begun to be studied in adult patients.(Awad et al., 2009; Awad & Lobo, 2012; Nygren, 
2006) However, it is unclear how repetitive pre-anesthetic fasting indirectly affects 
treatment responses through caloric restriction or how metabolic derangements induced 
by repetitive pre-anesthetic fasting affect pharmacogenetic responses to radiation or 
chemotherapy in pediatric patients. We expect that the preliminary data collected in this 
study will support future investigations into the metabolic effects of repetitive pre-
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anesthetic fasting and subsequent long-term outcomes that have not been evaluated in 
chronically ill children.  
Approach 
Introduction and Rationale 
We propose to test our central hypothesis that repetitive pre-anesthetic fasting 
negatively affects the nutritional status of pediatric patients with two specific aims. This 
hypothesis is based on a model for child malnutrition, the underlying mechanisms 
produced by fasting that lead to metabolic changes, and research findings describing the 
nutritional requirements that are often unmet in chronically ill children. 
Pediatric malnutrition model. An interdisciplinary working group of nurses, physicians, 
dietitians, and pharmacists, under the direction of the American Society of Parental and 
Enteral Nutrition (ASPEN), developed a definition and a key concept model of 
malnutrition using the best available evidence (Figure 1).(Mehta et al., 2013) Five 
domains were identified to describe pediatric malnutrition, which included anthropometric 
parameters and growth, etiology and chronicity, mechanisms, imbalance of nutrients, 
and outcomes. Pediatric malnutrition, related to undernutrition, was defined as the 
“imbalance between nutrient requirement and intake, resulting in cumulative deficits of 
energy, protein, or micronutrients that may negatively affect growth, development and 
other relevant outcomes.”(Mehta et al., 2013) The model and definition of malnutrition 
developed by the ASPEN group should be used for hospitalized children, but the 
working group emphasized that the model and definition addresses children in all 
settings, with the exception of malnutrition observed in the developing world or in 
neonates. Type and severity of disease were identified as two important variables that 
dictate nutrient requirements and a child’s ability to absorb and utilize nutrients. 
Conceptually, pediatric oncology patients undergoing RT may already be at risk for 
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malnutrition because of their diagnosis (etiology) and treatment (mechanism involving 
altered nutrient utilization and hypermetabolism). In addition, the subset of children 
undergoing AART may be placed at a higher risk for malnutrition because of the 
additional burden of intermittent, but repetitive, starvation periods (mechanism) resulting 
from pre-anesthetic fasting.  
Figure 1. Key concepts of malnutrition in hospitalized childrena 
 
aReproduced from Mehta et al., 2013.(Mehta et al., 2013) CDC, Centers for Disease Control and Prevention; 
MGRS, Multicenter Growth Reference Study; WHO, World Health Organization. 
Metabolic derangements of fasting. The metabolic effects of fasting have been 
described in the literature. Generally, fasting, or starvation, occurs when energy 
requirements exceed energy intake over a prolonged period of time.(Nygren, 2006) The 
body energy stored as carbohydrates, or hepatic glycogen, generally lasts for less than 
24 hours during a period of fasting, whereas protein and fat stores last much longer, 
approximately 21 days and 55 days, respectively.(Nygren, 2006) In adults, a 10%–15% 
weight loss in body weight typically does not lead to any significant functional 
derangements, but weight loss in the range of 30%–45% of body weight can become 
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life-threatening.(Nygren, 2006) In children, weight loss, or deceleration in weight gain, 
may result in significant metabolic derangements or death, depending on the underlying 
conditions present (e.g., illness), age and stage of development, and baseline energy 
stores.(Browning et al., 2006; Freemark, 2015; Ugochukwu, 2006) In sustained fasting 
conditions, or prolonged periods of time with decreased energy intake, metabolic 
adaptation occurs to decrease the rate of protein store depletion. However, as insulin 
and glucose concentrations decrease, both proteolysis (primarily in muscle) and lipolysis 
occurs.(Awad et al., 2009) Energy expenditure at rest increases as a result of 
gluconeogenesis and ketogenesis.(Awad et al., 2009; Webber & Macdonald, 1994) 
Additionally, even brief periods of fasting results in a significant decrease in insulin 
sensitivity.(Awad et al., 2009; Nygren, 2006) The development of insulin resistance has 
been associated with an increase in postoperative morbidity and mortality.(Awad & 
Lobo, 2012) Overall, pre-anesthetic fasting has been associated with an overall 
induction of metabolic stress and subsequent insulin resistance, which has been 
hypothesized to affect mitochondrial cellular processes as well as protein and gene 
expression.(Awad & Lobo, 2012) 
Nutritional status of chronically ill children. Close to 25% of hospitalized children are 
acutely malnourished, while close to 30% can be classified as being chronically 
malnourished.(Hendricks et al., 1995; Joosten & Hulst, 2008) Among hospitalized 
children, those with chronic medical conditions and younger than 2 years of age have a 
higher prevalence of protein-energy malnutrition.(Hendricks et al., 1995) Malnutrition is 
often unrecognized by clinicians, leading to approximately only one-third of 
undernourished hospitalized children receiving nutritional support.(Huysentruyt et al., 
2013; Silva et al., 2013) A recent study evaluating hospitalized children receiving 
nutritional support reported that even when ill children receive nutritional support, protein 
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and energy requirements are met in only about 38% and 33% of pediatric patients, 
respectively.(Mara et al., 2014) Fasting, including pre-anesthetic fasting, and fluid 
restrictions imposed for clinical reasons were the two most commonly cited reasons for 
not meeting nutritional target goals in the remaining group of children.(Mara et al., 2014) 
Research Design 
A retrospective cohort design will be employed to test our specific aims. Chart reviews 
will be conducted to abstract demographic, covariate, and outcome data. This proposed 
study design has been employed successfully in previous studies investigating both pre-
anesthetic fasting and nutritional status changes in chronically ill children.  
Participants and Procedure Patients treated at a large, 500+ bed academic and 
research cancer center, The University of Texas MD Anderson Cancer Center 
(MDACC), will be screened for study eligibility. Inclusion criteria will be limited to 
pediatric oncology patients (a) who are under 10 years of age as of October 1, 2015, 
and (b) who received any type of RT at MDACC between January 1, 2006, and October 
1, 2015, either with or without anesthesia. Patients with all cancer diagnoses will be 
included. Exclusion criteria will include (a) patients without a charted weight or 
length/height within 14 days of the start of radiation treatment, and (b) patients without a 
charted weight or length/height within 14 days after the completion of radiation 
treatment.  After institutional review board (IRB) approval, a medical record database 
query request will be submitted to the MDACC Clinical Analytics and Informatics 
Department. A list of medical record numbers for patients who meet the preliminary age 
and treatment inclusion criteria will be obtained. Electronic medical charts will be 
accessed and reviewed for inclusion criteria using the medical record numbers obtained 
from the MDACC Clinical Analytics and Informatics Department. Convenience, 
consecutive sampling of eligible patients will be performed, starting with the inclusion of 
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patients who were most recently treated until a sufficient sample size for each included 
group is obtained for analytical purposes.  
Variables and Data Collection/Abstraction Variables that will be abstracted from the 
electronic medical charts of patients are listed in Table 1. Data abstracted from charts 
will be entered into an electronic study database provided by the MDACC Biostatistics 
Department. 
Table 1. Study variables to be abstracted  
Demographic/ 
Patient 
characteristics 
Covariate Outcome 
Ethnicity and/or 
nationality 
Date of radiation simulation Height/length measure within 14 
days of start of RT (most recent to 
first day of RT) 
Sex Date of first and last day of RT Height/length measure within 14 
days of completion of RT (most 
recent to last day of RT) 
Date of birth Dates  of RT All height/length measures during 
RT 
Primary cancer 
diagnosis  
Dates of anesthetic 
administrations during RT 
(including simulation) 
All weight measures during RT 
Cancer grade 
and stage 
Start and end time of 
anesthesia billing time for 
each anesthetic administration 
during RT 
Weight measure within 14 days of 
start of RT (most recent to first day 
of RT) 
Secondary 
diagnoses 
Discharge time from recovery 
unit after each anesthetic 
administration during RT 
Weight measure within 14 days of 
completion of RT (most recent to 
last day of RT) 
Radiation site Dates of anesthetic 
administration to include any 
anesthetics within 1 month 
prior to start of radiation 
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treatment or during radiation 
treatment cycle 
Total radiation 
dose 
Documented referral/consult 
to clinical nutrition or ongoing 
management by clinical 
dietician 
 
Protocol  Documented diagnosis of 
nutritional deficiencies (ICD-9 
Codes 260-269.9) 
 
Radiation type Dose and type of prescribed 
dietary supplements 
 
Baseline 
nutritional status 
(weight for 
height z-score 
or BMI for age 
z-score) 
Type, duration, amount of 
enteral/tube feedings during 
RT 
cycle or within 14 days of start 
or end 
of RT cycle 
 
Dates of prescribed steroid 
therapy to include up to 3 
months prior to beginning of 
treatment, during or up to 14 
days after last day of 
treatment cycle 
 
Cumulative intravenous fluid 
administration during AART 
(type and total volume) 
 
Cumulative TIVA anesthetic 
dose (propofol) during AART 
 
Dates, doses and type of 
chemotherapy treatment to 
include any treatment within 1 
month prior to start of RT or 
during RT cycle (concomittant 
chemotherapy) 
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 All lab result values available 
from 14 days prior to start of 
RT up to 14 days after last 
date of RT including: 
 
- Total protein 
- Serum albumin 
- Pre-albumin 
- Ferritin 
- Hemoglobin 
- Hematocrit 
- Lipid profile 
- Liver function tests 
Pancreatic enzymes 
- White blood count 
- Total lymphocyte count 
- Bicarbonate 
- Lactic acid 
- Glucose 
- A1c  
 
 
Instruments Growth can be defined as the development into maturity, which can be 
observed as an increase in physical size.(Becker et al., 2015) Growth charts that allow 
the comparison of standard deviations (SD) from the norms in various reference age 
groups, that is, z-score comparisons, have been recommended for the evaluation and 
tracking of nutritional status in children.(Becker et al., 2015)  
World Health Organization Growth Standards, 0–24 months of age. The Centers for 
Disease Control and Prevention (CDC) recommends the use of World Health 
Organization (WHO) growth standards to evaluate infants and children from birth to 2 
years of age.(CDC National Center for Health Statistics, 2010) The WHO charts provide 
growth standards for infants who were predominantly breastfed during the first 4 months 
of life and continued to be breastfed until 12 months of age. The WHO charts present 
the rate at which small children should grow when provided with optimal alimentary 
conditions. In contrast, CDC charts identify how children in the US grew during a specific 
time period, which may not represent ideal growth patterns. Thus, the WHO standards 
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are better than the CDC standards for assessing physiological growth in early life. The 
methods and development of the most recent WHO growth standards have been 
published.(WHO Multicentre Growth Reference Study Group, 2009) 
Centers for Disease Control and Prevention Growth Standards,  24 months of 
age. The CDC recommends the use of the CDC growth standards to monitor the growth 
of children in the US who are 24 months of age or older.(CDC National Center for Health 
Statistics, 2010) The methods and development of the most recent CDC growth charts 
have been published(Kuczmarki, Ogden, Guo, & et al, 2002)  
Outcome Measures In their 2014 Pediatric Malnutrition Consensus Statement,(Becker 
et al., 2015) the Academy of Nutrition and Dietetics and the ASPEN recommended the 
use of various primary indicators as criteria for identifying and diagnosing malnutrition 
related to undernutrition when two or more anthropometric data points are available in 
children. The primary indicators that will be used to measure malnutrition in this 
exploratory study are shown in Table 2.   
Table 2. Included primary indicators for the assessment of malnutrition in childrenb  
Primary 
indicators 
Subject 
Age 
Mild 
malnutrition 
Moderate 
malnutrition 
Severe 
malnutrition 
Weight gain 
velocity(World 
Health 
Organization, 
2015b) 
< 24 months 
of age 
50x<75% of 
the norm for 
expected 
weight gain 
25x<50% of 
the norm for 
expected 
weight gain 
<25% of the 
norm for 
expected 
weight gain 
Weight loss   24 
months of 
age 
5 x 7.5% 
baseline 
body weight 
7.5 x 10% 
baseline 
body weight 
10% 
baseline body 
weight 
Deceleration in 
weight for 
length/height 
z-score(World 
All ages Decline of 1-
1.9 z-score 
Decline of 2-
2.9 z-scores 
Decline of  3 
z-scores 
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Health 
Organization, 
2015a) 
b Adapted from Becker et al., 2015.(Becker et al., 2015) 
Weight gain velocity in children < 24 months of age and weight loss in children   
24 months of age. Growth velocity is defined as the rate of change over time in weight 
or length/height.(Becker et al., 2015) The rate of change in growth can be used to 
assess a child’s health and nutritional status over time.(Iannotti, Zavaleta, Huasaquiche, 
Leon, & Caulfield, 2015)  Average rates of weight gain during periods of growth enable a 
child to maintain a stable rate of growth as determined by age and stage of development 
and evaluated by using the WHO growth standards. An example of a weight gain 
velocity chart depicted in 1-month weight increments for boys from birth to 12 months is 
included (Figure 2). Low weight gain velocities that may occur during time periods with 
insufficient rates of weight gain or weight loss in children have been independently 
related to higher mortality more closely than other malnutrition indicators.(O'Neill, 
Fitzgerald, Briend, & Van den Broeck, 2012) 
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Figure 2. 1-month weight increments percentiles (weight increase in grams) for 
boys, birth to 12 monthsc 
 
cReproduced from WHO weight velocity child growth standards, 2015(World Health Organization, 2015b) 
Deceleration in weight for length/height z-scores in all patients. Deceleration of 
weight over time is one of the terms used to define malnutrition.(Eskedal et al., 2008) 
The Academy of Nutrition and Dietetics and the ASPEN recommend the use of z-scores, 
namely, the decline in z-scores when comparing weight deceleration for length/height, to 
identify and evaluate malnutrition in children.(Becker et al., 2015) An example of a 
deceleration in weight for length chart for girls from birth to 24 months is included (Figure 
3). 
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Figure 3. Weight-for-length z-scores for girls, birth to 24 monthsd 
 
dReproduced from WHO z-score growth standards charts for girls, 2015(World Health Organization, 
2015a) 
 
Covariates Variables that may (a) influence the growth (weight/length or height) pattern 
of a child such as steroid treatment therapy,(Couluris et al., 2008; Muller et al., 2003) (b) 
contribute to malnutrition status such as concomitant chemotherapy,(Groot-Loonen, 
Otten, van't Hof, Lippens, & Stoelinga, 1996; Ladas et al., 2005; Sacks et al., 2014) or 
(c) may reflect metabolic derangements from repetitive fasting(Ilhan, Sari, Eren, & 
Tacyildiz, 2015; Ong, Han, Wong, & Lee, 2014) or anesthetic administration(Bhukal, 
Thimmarayan, Bala, Solanki, & Samra, 2014; Chauhan, Garg, & Bharadwaj, 2013; Ture, 
Mercan, Koner, Aykac, & Ture, 2009) (e.g., albumin  or triglyceride results) will be 
abstracted  as covariate data and controlled statistically.  
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Cumulative anesthetic dose. The majority of the children undergoing AART at MDACC 
receive total intravenous anesthetic (TIVA) administration.(Owusu-Agyemang et al., 
2014) Propofol is the anesthetic of choice for TIVA at MDACC. Propofol is an anesthetic 
that is formulated in a 10% intravenous fat emulsion, (Mirtallo, Dasta, Kleinschmidt, & 
Varon, 2010) and provides 1.1 kcal/mL.(Lowrey, Dunlap, Brown, Dickerson, & Kudsk, 
1996) The cumulative anesthetic dose (mg/kg) that each patient receives during AART 
will be abstracted and total calories received through propofol infusions calculated. The 
total number of calories provided by propofol will be used as a covariate in subsequent 
analyses. 
Cumulative intravenous fluid administration. Children receiving TIVA during AART 
also receive intravenous fluids (IVFs). Intravenous fluids containing dextrose provide 
calories. For example, a 5% dextrose solution on average provides 170kCal/L while a 
Plasma-Lyte R solution provides 17kCal/L.(Lutz, Litch, Mazur, STAT!Ref, & Teton Data 
Systems, 2015) The type of IVF administered for each anesthetic in every patient and 
the total volume of intravenous fluid administered during AART will be abstracted. The 
total number of calories provided by IVFs will be used as a covariate in subsequent 
analyses. 
Experimental Approach  
Specific Aim 1. Determine the association between total pre-anesthetic fasting days 
and primary indicators for nutritional status in pediatric patients under 10 years of age 
during an RT cycle.  Hypothesis: Higher number of pre-anesthetic fasting days during an 
RT cycle will be associated with worse nutritional status. The length of RT cycles varies 
based on cancer diagnosis, tumor location, treatment protocol, and RT type, among 
other things. Radiation treatment cycles at MDACC for pediatric oncology patients range 
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from approximately 2 to 6 weeks. Children under the age of 10 years receiving RT with 
and without anesthesia will be included to test Specific Aim 1. A varying number of total 
pre-anesthetic fasting days during an RT cycle will be included. Most children under 6 
years of age receive AART, whereas those over 6 years of age may or may not receive 
AART, depending on their ability to remain immobile during treatment. We anticipate that 
the total number of pre-anesthetic fasting days during an RT cycle will range from 0–30 
days in children over 6 years of age (Table 3), whereas the total number of pre-
anesthetic fasting days will range from 10–30 days in children under 6 years of age 
(Table 3). Outcome measures used differ for children  24 months (weight gain velocity, 
deceleration in weight for length/height z-score) and those  24 months (weight loss, 
deceleration in weight for length/height z-score). Outcomes (dependent variables) will be 
coded as dichotomous (no malnutrition/malnutrition) or ordinal (mild, moderate, or 
severe malnutrition), depending on the statistical approach. Risk for malnutrition will be 
evaluated by using the total number of pre-anesthetic fasting days as an independent 
variable while controlling for covariates. Among patients with an outcome of malnutrition 
status, risk factors will be determined for worse outcome.   
 
Specific Aim 2. Determine the association between total non-fasting days and primary 
indicators for nutritional status in pediatric patients under 10 years of age during an RT 
cycle. Hypothesis: Higher number of non-fasting days during an RT cycle will be 
associated with better nutritional status. The length of RT cycles varies based on various 
factors, as mentioned previously. Children under the age of 10 years receiving RT with 
and without anesthesia will be included to test Specific Aim 2. A varying number of total 
non-fasting days during an RT cycle will be included. We anticipate that the total number 
of non-fasting days during an RT cycle will range from 2–40 days in children over 6 
years of age (Table 3), whereas the total number of non-fasting days will range from 2–
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10 days in children under 6 years of age (Table 3). Additionally, we anticipate that the 
total number of non-fasting days will vary slightly within each group from those estimated 
for clinical (e.g., febrile child where AART is cancelled) and non-clinical (e.g., treatment 
day falling on a weekday holiday) reasons. Outcome measures used differ for children  
24 months (weight gain velocity, deceleration in weight for length/height z-score) and 
those  24 months (weight loss, deceleration in weight for length/height z-score). 
Outcomes will be coded as dichotomous (no malnutrition/malnutrition) and ordinal (mild, 
moderate, or severe malnutrition), depending on the statistical approach. Risk for 
malnutrition will be evaluated by using total non-fasting days as an independent variable 
while controlling for covariates. Among patients with an outcome of malnutrition status, 
risk factors will be determined for worse outcome while controlling for non-fasting days.  
 
Table 3. Estimated number of total pre-anesthetic fasting and non-fasting days 
Length of RT  
(range, estimated shortest 
to longest) 
AART* RT without 
Anesthesia 
FD NFD FD NFD 
2 weeks 
 10 weekdays 
 4 weekend days, 
inclusive 
10 2–4 0 12–14 
6 weeks 
 30 weekdays 
 12 weekend days, 
inclusive 
30 10–12 0 40–42 
AART, Anesthesia-Assisted Radiation Therapy; FD, pre-anesthetic fasting days; NFD, non-fasting days; 
RT, Radiation Therapy; * = Most children under 6 years of age will receive AART;  = Some children 
over 6 years of age will be capable of receiving RT without anesthesia.  
 
Expected Outcomes We expect that this exploratory study will determine the 
associations between repetitive pre-anesthetic fasting and nutritional status changes in 
pediatric patients over an RT period. We expect to determine the effect that an 
increasing number of total pre-anesthetic fasting days has on the development of 
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malnutrition. Findings will be confirmed by then determining whether an increasing 
number of non-fasting days is found to decrease the risk for malnutrition. Additionally, 
among those children found to be malnourished at the end of RT, risk factors will be 
evaluated for varying levels of malnutrition (mild, moderate, and severe) while controlling 
for covariates.  
Statistical Approach Data will be analyzed in consultation with an assigned 
biostatistician from the MDACC Biostatistics Department. Descriptive statistics will be 
used to evaluate patient characteristics of the study sample. Chi-square tests will be 
used to compare the distribution of baseline nutritional status across primary cancer 
diagnoses. Differences in groups regarding the presence or absence of malnutrition at 
the end of RT will be estimated by using univariate and multivariate binary logistic 
regression, yielding odds ratios (ORs) and 95% confidence intervals (95% CI). Ordinal 
logistic regression will be used to evaluate risk factors for mild, moderate, and severe 
malnutrition. Significance levels will be established at p < 0.05. The recommended 
sample size estimates for regression models vary, but a sample size of at least 5–10 
cases per variable is acceptable.(Findley & Daum, 1989; Harrell, Lee, Matchar, & 
Reichert, 1985; Hsieh, Bloch, & Larsen, 1998; Sackett, Haynes, Guyatt, & Tugwell, 
1991) A minimum of 120 patients will be included in this exploratory study, which is our 
estimated required sample size for statistical analyses.  
Specific Aim 1. Univariate analysis will be used to examine the relationship between 
total number of pre-anesthetic fasting days and malnutrition status at the end of RT. Age 
will be categorized and divided into ranges so that trends within age groups can be 
identified. Multivariate logistic regression will be used to evaluate if a higher number of 
pre-anesthetic fasting days is associated with malnutrition status at the end of RT.  
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Specific Aim 2. Univariate analysis will be used to examine the relationship between 
total number of non-fasting days and malnutrition status at the end of RT. Age will be 
categorized and divided into ranges so that trends within age groups can be identified. 
Multivariate logistic regression will be utilized to evaluate if a higher number of non-
fasting days is associated with non-malnutrition status at the end of RT.  
Potential Problems and Alternative Approaches 
Missing data due to incomplete documentation because of the nature of retrospective 
chart reviews is the main potential challenge for the proposed study. All data will be 
abstracted from electronic medical records, which were incorporated into the MDACC 
system starting in 2006. Patients will be excluded if height/length or weight have not 
been captured in the medical record prior to and after RT. Rules and a study protocol 
regarding the management of missing data for covariates or demographic variables will 
be devised prior to data collection. Whenever possible, missing data points will be 
imputed through statistical analysis.(Dworkin, 1987; Worster & Haines, 2004) In cases 
when data imputation cannot be done, the entire case will be excluded from statistical 
analyses. To account for potential exclusion or deletion of cases, oversampling by 15% 
will occur. Data will be abstracted from a total of 138 electronic medical charts from 
eligible patients. Another potential challenge is ensuring that we have access to the 
minimum number of medical records of for eligible patients. However, based on a 
recently published study investigating AART at MDAAC,(Owusu-Agyemang et al., 2014) 
we estimate that at least 180 charts from patients who meet the inclusion criteria are 
available for review. These charts are for pediatric oncology patients under 10 years of 
age who received anesthesia-assisted proton therapy between January 1, 2006, and 
January 1, 2014. We anticipate that the number of eligible patients is actually much 
higher given that we expect to also recruit patients who (a) received RT other than 
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proton therapy, (b) received RT without anesthesia, and (c) received RT after January 1, 
2014.  
Protection of Human Subjects 
 
We expect that the IRB will waive informed consent requirements because of the 
retrospective research design of this study. No direct risk will be imposed on patients. All 
data will be de-identified upon abstraction from medical records. All electronic data will 
be encrypted and password-protected using institutional standards. Laptops and files 
(hard and soft copy) will be physically secured in a designated location at the UTHealth 
School of Nursing or at MDACC, as established by the primary researchers. Only key 
personnel (i.e., data collectors or primary researchers) will have access to study data, 
and only to data necessary to complete assigned tasks. Data will be destroyed after IRB 
approval expiration or minimum amount of time required for data retention has elapsed 
(whichever is longer). To ensure proper data destruction, physical files will be shredded 
while electronic files will be overwritten at the file and block level with specialized 
software.  
 
Future Directions 
This exploratory study will broaden our understanding of iatrogenic-related malnutrition 
by providing knowledge regarding the association between repetitive pre-anesthetic 
fasting and nutritional status changes and, if found, the strength of this association. We 
also expect to determine the extent to which non-fasting days or breaks from 
intermittent, repetitive fasting may ameliorate worse nutritional status changes. This 
work builds upon a conceptual model of malnutrition for ill children. We expect that the 
preliminary data collected in this study will support future research on the metabolic 
effects of repetitive pre-anesthetic fasting and subsequent long-term outcomes that have 
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not yet been evaluated in pediatric oncology patients, in particular, or chronically ill 
children, in general.  
In future studies, we plan to investigate the potential indirect benefits of caloric restriction 
produced by repetitive pre-anesthetic fasting and cancer treatment responses in 
pediatric oncology patients undergoing AART.  We also plan to investigate the 
interactions between the metabolic responses (e.g., insulin resistance) from repetitive 
pre-anesthetic fasting, along with baseline characteristics (e.g., malnutrition 
preoperatively) and subsequent long-term, post-treatment outcomes (e.g., length of stay, 
event-free survival). 
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MANUSCRIPT 
Introduction 
In the United States, pediatric cancers are rare, representing only 1% of all newly 
diagnosed cancers(American Cancer Society, 2014), but they are the leading cause of 
death by disease in children after infancy.  Each year, 1 in 285 children are diagnosed 
with cancer before 20 years of age(American Cancer Society, 2014), with leukemia, 
brain and central nervous system tumors, and lymphoma being the most common 
pediatric cancers.  Due to advances in treatment, the overall prognosis for children with 
cancer has improved greatly over the past several decades(Cancer incidence and 
survival among children and adolescents: United states SEER program 1975-
1995.1999).  For example, the 5-year survival rate of children diagnosed with cancer 
before 20 years of age was 50% in 1975, compared with more than 80% in 2004–
2010(SEER cancer statistics review, 1975-2012.).  However, in conjunction with this 
improvement in survival, there has been an increase in the incidence of pediatric 
cancers, which means that pediatric oncology patients will remain a considerable 
population both as patients and survivors. 
In addition to type and severity of disease, nutritional status is an important 
determinant of outcomes in pediatric oncology patients during both treatment and 
survivorship(Brinksma et al., 2015).  In these patients, malnutrition may result from the 
disease as well as its treatment.  Although the etiology and prevalence of malnutrition 
remain unclear(Brinksma et al., 2012; Co-Reyes, Li, Huh, & Chandra, 2012), its 
consequences are clear.  Specifically, malnutrition has been associated with more 
treatment complications, higher relapse rates, and lower survival rates among pediatric 
oncology patients(Brinksma et al., 2012).  Thus, correctly identifying and adequately 
treating malnutrition in pediatric oncology patients is critical for ensuring positive short-
term and long-term outcomes.  To this end, an interdisciplinary working group of nurses, 
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physicians, dietitians, and pharmacists, under the direction of the American Society of 
Parental and Enteral Nutrition (ASPEN), has developed a definition and a key concept 
model of malnutrition using the best available evidence(Mehta et al., 2013).  The ASPEN 
working group identified five domains to describe pediatric malnutrition, which include (1) 
anthropometric parameters and growth, (2) etiology and chronicity, (3) mechanisms, (4) 
imbalance of nutrients, and (5) outcomes.  The ASPEN working group also identified 
type and severity of disease as two important variables that dictate a child’s nutrient 
requirements and his or her ability to absorb and utilize nutrients, which, in turn, directly 
affects his or her nutritional status.  Pediatric malnutrition, which is primarily related to 
undernutrition, is defined as the “imbalance between nutrient requirement and intake, 
resulting in cumulative deficits of energy, protein, or micronutrients that may negatively 
affect growth, development and other relevant outcomes(Mehta et al., 2013).”  The 
ASPEN working group’s model and definition of malnutrition apply to children in all 
settings, with the exception of malnutrition observed in the developing world or in 
neonates.  Although malnutrition has been defined and conceptualized and is 
recognized as resulting in serious consequences, its causes in this population require 
further elucidation. 
A possible cause of malnutrition in pediatric oncology patients is fasting prior to 
undergoing anesthesia.  Pediatric oncology patients undergo multiple diagnostic and 
therapeutic procedures during their course of illness that require anesthesia to ensure 
immobility during non-invasive procedures(Buchsbaum et al., 2013; Latham, 2014; 
McFadyen, Pelly, & Orr, 2011; Scheiber, Ribeiro, Karpienski, & Strehl, 1996).  Current 
practice guidelines for pre-anesthetic fasting recommend that children abstain, at a 
minimum, from breast milk for 4 hours, from clear liquids for 2 hours, and from 
nonhuman milk or light meal for 6 hours prior to anesthesia(American Society of 
Anesthesiologists Committee, 2011). In actual practice, however, anesthetic providers 
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use their clinical judgment to determine the appropriate minimum fasting time prior to 
each anesthetic administration, so reported pre-anesthetic fasting times are usually 
much longer than the minimum recommendations(Arun & Korula, 2013; Hancock, 
Cresci, & Martindale, 2002; Williams et al., 2014).  Pediatric oncology patients receiving 
radiation therapy (RT) may already be at risk of malnutrition because of their diagnosis 
(etiology) and treatment (mechanism involving altered nutrient utilization and 
hypermetabolism).  Moreover, the subset of children undergoing anesthesia-assisted RT 
(AART) may be placed at an even higher risk of malnutrition because of the additional 
burden of intermittent, but repetitive, starvation periods (mechanism) resulting from pre-
anesthetic fasting.  Despite these gaps in knowledge and the clinical implications of 
malnutrition in pediatric radiation oncology patients, no studies have examined repetitive 
instances of pre-anesthetic fasting or evaluated anesthesia-related nutritional status 
changes as an outcome in pediatric patients; specifically, no studies have investigated 
the association between repetitive pre-anesthetic fasting and malnutrition in pediatric 
oncology patients undergoing RT.  
Accordingly, in the current study, the association between repetitive fasting and 
nutritional status in pediatric oncology patients under 10 years of age who received any 
type of RT with or without anesthesia at a tertiary care hospital was investigated.  Based 
on a model for child malnutrition, the underlying mechanisms produced by fasting that 
lead to metabolic changes(Awad, Constantin-Teodosiu, Macdonald, & Lobo, 2009; Awad 
& Lobo, 2012; Nygren, 2006), and research indicating that nutritional requirements are 
often unmet in chronically ill children(Groleau et al., 2014; Hendricks et al., 1995; 
Huysentruyt et al., 2013; Joosten & Hulst, 2008; Mara et al., 2014; Silva et al., 2013),  it 
was hypothesized that repetitive pre-anesthetic fasting negatively affects the nutritional 
status of these patients and that non-fasting mitigates the risk for malnutrition.  To test 
this hypothesis, (1) the association between pre-anesthetic fasting days and primary 
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indicators for malnutrition, and (2) the association between non-fasting days and primary 
indicators for malnutrition in children undergoing AART during an RT cycle were 
investigated.  Research findings could advance the study of the underlying metabolic 
mechanisms of repetitive, pre-anesthetic fasting on nutritional status (e.g., post-
treatment insulin resistance) and subsequent long-term outcomes (e.g., treatment 
response, event-free survival rate) in pediatric oncology patients. 
 
Methods 
Study Population  
After approval by The University of Texas MD Anderson Cancer Center 
Institutional Review Board and The University of Texas Health Science Center at 
Houston (UTHealth) Committee for the Protection of Human Subjects, a retrospective 
cohort was assembled of pediatric oncology patients (≤ 10 years) who received any type 
of RT with or without anesthesia at a tertiary care hospital between January 1, 2006, and 
October 1, 2015.  Eligible subjects were patients who had a charted height and weight 
within 14 days of both the start date and end date of RT.  Consecutive screening of 
eligible patients was performed, starting with the inclusion of patients who were most 
recently treated until 138 eligible patients were identified.  The recommended sample 
size estimates for regression models vary, but a sample size of at least 10 cases per 
variable is acceptable(Findley & Daum, 1989; Harrell, Lee, Matchar, & Reichert, 1985; 
Hsieh, Bloch, & Larsen, 1998; Sackett, Haynes, Guyatt, & Tugwell, 1991).  A minimum 
of 120 patients was estimated for statistical analysis, but to account for potential 
exclusion or deletion of cases, oversampling by 15% was performed.      
Data Collection and Extraction 
The medical record of each eligible patient was reviewed to extract data on 
demographics, diagnostics, and anesthetic history.  Data were extracted, when 
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available, on anthropometric (length/height and weight) measurements, anesthetic 
administration, and laboratory values from up to 14 days before the start of RT to 14 
days after the end of RT.  For each patient, a baseline and a final charted weight 
(kilograms) and length/height (centimeters) to the nearest tenth were recorded.  Final 
charted heights < 2 cm from baseline heights were considered invalid and attributed to 
equipment or operator error; thus, final charted heights in 3 patients were changed 
manually to the next most recently charted height near the end of RT.  When a 
measured height was missing for a corresponding weight on the same day, the previous 
or next available charted height (whichever was closest to the day when the charted 
weight was recorded) was used if both the charted height and weight fell within 14 days 
of the start (for baseline values) or end (for final values) of RT.  Time intervals between 
baseline and final anthropometric values ranged from 9 to 64 days for RT cycles lasting 
between 8 and 54 days, respectively.         
Assessment of Malnutrition 
Because anthropometric data were available, three primary indicators were used 
for malnutrition (low weight gain velocity, weight loss, and deceleration in weight for 
length/height z-score) that are recommended in the 2014 Pediatric Malnutrition 
Consensus Statement(Becker et al., 2015) by the Academy of Nutrition and Dietetics 
and ASPEN to assess malnutrition at baseline and at the end of RT.  As recommended 
by the U.S. Centers for Disease Control and Prevention (CDC)(Grummer-Strawn, 
Reinold, Krebs, & Centers for Disease Control and Prevention (CDC), 2010), z-scores 
were derived using the 2006 World Health Organization (WHO) growth standards(World 
Health Organization, 2006) for patients younger than 2 years and the 2000 CDC growth 
standards(Kuczmarski et al., 2002) for patients 2 years of age and older.  Z-scores were 
calculated using a medical calculator for clinical providers (www.peditools.org)(Chou, 
2015).  For patients younger than 2 years, the percentile rank of their weight increment 
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was estimated using the 2009 WHO Child Growth Standards(WHO Multicentre Growth 
Reference Study Group, 2009) weight velocity percentile charts.  
To assess malnutrition at baseline, weight for length/height z-score or body mass 
index (BMI) for age z-score was used as the primary malnutrition indicator because one 
anthropometric data point was available (length/height and weight at start of RT).  For 
patients with length/height < 121.5 cm, weight for length/height z-scores were used; for 
patients with length/height > 121.5 cm, BMI for age z-scores were used.  Malnutrition at 
baseline was defined as either a weight for length/height z-score or a BMI for age z-
score  –1.  
To analyze the correlations between malnutrition indicators and variables of 
interest, percent weight change from baseline (continuous variable), differences between 
baseline and final z-scores (continuous variable), and weight gain velocity percentiles 
(ordinal variable) were used.  Weight gained between the start and end of RT was 
unable to be used as a continuous variable for weight gain velocity because these 
values are only meaningful when interpreted using weight gain velocity percentile charts 
according to a patient’s gender, age, and the time interval when growth was measured.  
Therefore, for weight gain velocity, patients < 2 years of age were coded as “0,” not 
malnourished ( 75% expected weight gain); “1,” mildly malnourished (50%  × < 75% 
expected weight gain); “2,” moderately malnourished (25%  × < 50% expected weight 
gain); or “3,” severely malnourished (< 25% expected weight gain).  
Logistic regression models were then constructed to assess malnutrition at the 
end of RT. Low weight gain velocity, weight loss, and deceleration in weight for 
length/height z-score as the primary malnutrition indicators were used because two 
anthropometric data points were available (baseline and final length/height and weight).  
Malnutrition at end of RT was defined as (1) weight loss  5% of baseline weight in 
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patients  2 years of age, (2) weight for length/height z-score decline  1 z-score in 
patients  121.5 cm in length/height, and (3) weight gain velocity < 75% of the expected 
weight gain in patients  2 years of age.   
Cumulative malnutrition, used as the outcome in the logistic regression models, 
was coded as a dichotomous variable: “1” for malnutrition or “0” for absence of 
malnutrition.  Patients with a weight for length/height z-score or BMI for age z-score  –1 
at the start of RT were coded as malnourished at baseline.  Cumulative malnutrition at 
baseline was derived by combining results from the two malnutrition indicators used 
(weight for length/height and BMI for age z-scores).  At baseline, there was no overlap in 
malnutrition assessment between these two indicators.  Patients with an expected 
weight gain velocity < 75% (age < 2 years), a decline of  1 z-score in weight for 
length/height (length/height < 121.5 cm), or weight loss  5% (age  2 years) from 
baseline were coded as malnourished at the end of RT.  Cumulative malnutrition at the 
end of RT was derived by combining results from the three malnutrition indicators used 
(weight gain velocity, z-score, and percent weight changes).  Patients were coded as 
malnourished at end of RT if they met the criteria for malnutrition according to any 
indicator.  There was a discrepancy of malnutrition indicator coding between patients  2 
years of age but  121.5 cm in height and patients < 2 years of age.  At the end of RT, 
102 patients between the ages of 2 and 10 years of age had both calculated weight for 
length/height z-score and percent weight loss changes.  Of these patients, 10 were 
coded as malnourished by percent weight loss, but not by declines in z-scores, whereas 
2 were coded as malnourished by declines in z-scores, but not by percent weight loss. 
These 12 patients were coded as malnourished when scores were combined in 
cumulative malnutrition (Supplemental Table I).  Furthermore, at the end of RT, 18 
patients younger than 2 years had both calculated weight gain velocity and weight for 
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length/height z-score changes.  Of these patients, 9 were coded as malnourished by low 
percentile weight gain velocities, but not by declines in z-scores. These 9 patients were 
coded as malnourished when scores were combined in evaluating cumulative 
malnutrition (Supplemental Table I).  
Statistical Analyses 
After verifying data for accuracy and completeness and analyzing distribution of 
continuous variables for assumptions of normality, non-parametric tests were used to 
analyze data that did not meet statistical assumptions.  Descriptive statistics were used 
to summarize patient characteristics.  Chi-square tests (2) were used to compare 
differences in the proportion of patients with malnutrition at baseline and at end of RT; 
between RT cohorts (AART vs. non-AART); and among age groups (< 2 years vs. 2–5 
years vs. > 5 years) in the AART cohort, which is the cohort of patients who underwent 
repetitive, pre-anesthetic fasting.  Pearson’s correlation, or if more appropriate, 
Spearman rank correlation (rs), was used to assess the strength of correlations between 
the number of fasting or non-fasting days, along with other select covariates of interest, 
and malnutrition at the end of AART.  Primary indicators were: (1) percent weight 
change, (2) weight for height/length z-score differences as continuous variables, and (3) 
weight gain velocity as an ordinal variable (on an ordinal scale coded from absence of 
malnutrition to severe malnutrition).   
To further assess the relationship between patient characteristics and 
malnutrition, logistic regression models were constructed to examine pre-anesthetic 
fasting and non-fasting days as predictors for malnutrition at the end of AART, while 
adjusting for select patient and treatment-related variables of interest.  For logistic 
regression models, malnutrition status both at baseline and at the end of RT was 
dichotomized by combining the results of the primary indicators.  All statistical analyses 
were performed using IBM SPSS Statistics Version 23 (IBM Corp., Armonk, NY). 
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Results 
Patient Characteristics 
Patient characteristics are shown in Table I.  The median age (interquartile range 
[IQR]) at baseline was 5 years (3.25–7.13).  Most patients were male (58.0%) and white 
(62.3%); diagnosed with either brain (52.9%) or extracranial solid (44.9%) tumors; and 
received AART (66.0%) with concurrent chemotherapy (63.0%).  In terms of age, 
patients in the AART cohort (median age = 3.8 years, IQR = 2.6–5.1) were younger than 
those in the non-AART cohort (median age = 7.8 years, IQR = 6.1–8.9).  All patients < 2 
years received AART as did the vast majority (96%) of patients aged 2–5 years.  The 
duration of RT cycles between the AART (median duration = 40 days, IQR = 2943) and 
non-AART (median duration = 39 days, IQR = 2942) cohorts were similar 
(Supplemental Table II).  The cumulative propofol and intravenous fluid received by the 
AART cohort are shown in Supplemental Table III.  
Malnutrition at Baseline and at End of Radiation Therapy 
Overall, the prevalence of cumulative malnutrition at baseline was 18.8%, which 
increased to 26.8% at the end of RT, and the cumulative incidence of malnutrition was 
28.6% over a maximum RT cycle duration of 56 days (N = 138, Supplemental Table IV 
and Supplemental Table V).  Malnutrition at baseline did not differ significantly among 
age groups in the AART cohort [2 (2, N = 91) = 1.93, p = 0.38] or between the AART 
and non-AART cohorts [2 (1, N = 138) = 0.004, p = 1.0].  However, at the end of AART, 
patients < 2 years had a significantly higher rate of malnutrition (n = 10/18, 55.6%) than 
those aged 2–5 years (n = 13/47, 27.7%) [2 (1, N = 65) = 4.43, p = .046].  Furthermore, 
at the end of RT, patients who received AART (n = 31/91, 34.1%) had a significantly 
higher rate of malnutrition than those who did not receive AART (n = 6/47, 12.8%) [2 (1, 
N = 138) = 7.17, p = 0.008]. 
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Correlations between Malnutrition Indicators and Number of Fasting and Non-
Fasting Days 
In the AART cohort, which comprised patients who experienced repetitive, pre-
anesthetic fasting, a significant correlation was found between weight gain velocity and 
the number of non-fasting days (rs = –0.49, p = 0.039), that is, as number of non-fasting 
days increased, the presence and severity of malnutrition decreased.  No other 
significant correlations were found between primary malnutrition indicators and fasting or 
non-fasting days. 
Univariate Logistic Regression Analyses  
Number of fasting and non-fasting days, which were analyzed in 5-day 
increments because of consecutive weekday RT treatment schedules, were not 
significant predictors of malnutrition status at the end of AART (Table II).  Other potential 
predictors of malnutrition were also examined, such as primary cancer diagnosis, 
concurrent chemotherapy, malnutrition at baseline, age, and gender.  Of these, only age 
was found to be a significant predictor of malnutrition.  Specifically, patients 25 years of 
age had lower odds than those younger than 2 years of age of becoming malnourished 
by the end of AART (odds ratio [OR] = 0.31, p = 0.04).  Concurrent chemotherapy 
trended towards significance as a predictor of malnutrition at the end of AART (OR = 
2.62, p = 0.055).  Lastly, when all RT patients (both AART and non-AART cohorts) were 
included in the analysis, receiving AART was a significant predictor of malnutrition when 
compared to not receiving AART (OR = 3.531, p = 0.01).  
Multivariate Logistic Regression Analyses 
Given the results of the univariate regression analyses, age and concurrent 
chemotherapy were tested as predictors for malnutrition in a multivariate regression 
model.  When considered together, age and concurrent chemotherapy were significant 
predictors of malnutrition at the end of AART (Table III, Model 1).  Specifically, after 
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adjusting for age, patients who received concurrent chemotherapy had higher odds than 
those who did not receive concurrent chemotherapy of becoming malnourished by the 
end of AART (OR = 3.48; p = 0.024).  In addition, after adjusting for concurrent 
chemotherapy status, patients 2 years of age and older had lower odds than those 
younger than 2 years of age of becoming malnourished by the end of AART (OR = 0.23, 
p = 0.018 for patients  2 to < 5 years; OR = 0.26, p = 0.047 for patients  5 years).  
Furthermore, concurrent chemotherapy and older age remained significant predictors of 
malnutrition at the end of AART, even after adjusting for pre-anesthetic fasting days and 
non-fasting days (Table III, Models 2 and 3).  Lastly, after adjusting for concurrent 
chemotherapy status and age, patients who received AART did not have higher odds 
than those who did not receive AART of becoming malnourished by the end of RT 
(Table III, Model 4).  
Discussion 
In this exploratory study, the association between pre-anesthetic fasting days 
and primary indicators for malnutrition, as well as the association between non-fasting 
days and primary indicators for malnutrition in patients receiving AART were examined.  
It was found that the number of pre-anesthetic fasting days was not significantly 
associated with any primary indicators of malnutrition. However, the number of non-
fasting days was significantly correlated with the absence of malnutrition as determined 
by weight gain velocity for patients younger than 2 years in the AART cohort.  By the end 
of AART, neither the number of pre-anesthetic fasting days nor the number of non-
fasting days was a significant predictor for presence of malnutrition.  Collectively, these 
findings do not support the hypothesis that repetitive, pre-anesthetic fasting negatively 
affects the nutritional status of pediatric oncology patients receiving AART or that an 
increasing number of non-fasting days during an AART cycle mitigates the risk of 
malnutrition.  
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In addition, it was found that the rates of malnutrition by the end of RT differed 
significantly by RT cohort (AART vs. non-AART).  Specifically, patients in the AART 
cohort had a significantly higher rate of malnutrition than patients in the non-AART 
cohort.  However, on multivariate logistic regression analysis, receiving AART was not a 
significant predictor of malnutrition, after controlling for age and concurrent 
chemotherapy administration. This finding suggests that age and/or concurrent 
chemotherapy and receiving AART are correlated.  When analyzed, there was 
multicollinearity between receiving AART and age.  The multicollinearity between AART 
and age can be explained by the fact that the AART cohort was mainly composed of 
younger patients (< 5 years) compared with the non-AART cohort.  Because most young 
patients tend to receive AART to ensure immobility during RT, when age was controlled 
for, receiving AART no longer made a significant contribution to the model prediction.  
Within the AART cohort, patients younger than 2 years of age had significantly 
higher rates of malnutrition than those 2–5 years of age.  This finding was corroborated 
by univariate and multivariate logistic regression analysis, which revealed that patients 2 
years of age and older had lower odds than those younger than 2 years of age of 
becoming malnourished at the end of AART.  This finding suggests that younger patients 
are more vulnerable than older patients to disease and/or treatment effects that may 
lead to malnutrition.  It also suggests that growth impairment as operationalized by 
weight gain velocity is a more sensitive indicator of malnutrition than deceleration in 
weight for length/height z-scores in patients younger than 2 years of age.  Specifically, of 
the 10 total cases of malnutrition in children under 2 years of age, 9 were identified by 
weight gain velocity only, whereas 1 case was identified by both weight gain velocity and 
deceleration in weight for length/height z-score at the end of AART.  However, the high 
detection rate of malnutrition by low weight gain velocity, along with a small sample size 
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of patients younger than 2 years of age (n = 18), may have falsely driven the rate of 
malnutrition higher in this age group compared with that in the other two age groups.   
The possible implication of the relative sensitivity of the indicators of malnutrition 
used in the current study is important for two reasons.  First, there is no agreement on 
which indicators should be used to evaluate malnutrition in pediatric oncology 
patients(Brinksma et al., 2012; Loeffen, Brinksma, Miedema, de Bock, & Tissing, 2015), 
so studies generally use different indicators.  Second, even when studies use the same 
indicators, different criteria are used to categorize or analyze malnutrition(Altaf et al., 
2013; Esbenshade et al., 2011; Ethier et al., 2012; Orgel et al., 2014; Withycombe et al., 
2015).  Briefly, the following indicators of malnutrition with different cutoff values have 
been used: the Netherlands BMI for age z-scores(Loeffen et al., 2015), CDC BMI for age 
percentiles(Altaf et al., 2013; Esbenshade et al., 2011; Ethier et al., 2012; Orgel et al., 
2014; Withycombe et al., 2015), CDC BMI for age z-scores(Esbenshade et al., 2011), 
CDC weight for length z-scores(Esbenshade et al., 2011; Orgel et al., 2014), United 
Kingdom adjusted BMI z-scores(Aldhafiri, McColl, & Reilly, 2014), United States National 
Health and Nutritional Examination Survey (NHANES) 1971-1974 triceps skin fold 
thickness percentiles(Antillon et al., 2013; Sala et al., 2012), NHANES 1971-1974 mid 
upper arm circumference percentiles(Antillon et al., 2013; Sala et al., 2012), weight 
loss(Loeffen et al., 2015), and albumin lab values(Sala et al., 2012).  To help improve 
the overall quality of studies evaluating malnutrition in pediatric oncology patients, cutoff 
scores must be determined and standardized according to their clinical 
relevance(Loeffen et al., 2015).  In their review of the prevalence of malnutrition in 
pediatric oncology patients, Brinksma et al.(Brinksma et al., 2012) recommended that 
the WHO growth standards be used in conjunction with BMI cutoff scores derived from 
an international survey(Cole, Flegal, Nicholls, & Jackson, 2007), which would enable 
comparisons among studies evaluating malnutrition in pediatric oncology patients.  
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Brinksma et al. also recommended that weight loss and body composition changes (e.g., 
fat free mass and fat mass) be included.  To date, however, Brinksma et al.’s 
recommendations have not been evaluated against those of the 2014 Pediatric 
Malnutrition Consensus Statement(Becker et al., 2015) by the Academy of Nutrition and 
Dietetics and ASPEN, which were followed in this study.  Thus, more research is needed 
to determine which malnutrition indicator(s), as well as cutoff score(s), is the most 
clinically relevant when evaluating malnutrition in pediatric oncology patients, in general, 
and in those undergoing RT, in particular.   
This study has some important limitations that should be considered when 
interpreting its findings.  First, this exploratory study has a retrospective observational 
design.  Thus, limited control existed over (1) the quality or completeness of data 
entered into medical records, (2) patient assessment and follow up between and within 
cohorts, and (3) construction of cohorts. Second, the sample size was small, which 
decreased the precision of the significant findings (i.e., generated wide confidence 
intervals); however, it is comparable to those of other studies investigating AART-related 
outcomes(Buchsbaum et al., 2013).  Third, anthropometric measurements were 
extracted from medical records, limiting their reliability, accuracy, and completeness.  
For example, 3 cases with negative values for height over time, which were attributed to 
equipment or operator error, were manually adjusted.  Fourth, the study findings cannot 
be compared with those of other studies because of the paucity of existing data on 
nutritional status changes related to repetitive pre-anesthetic fasting in pediatric patients, 
in general, and in pediatric oncology patients undergoing RT, in particular.  Fifth, most of 
the study cohort received proton therapy, so study findings may only be generalized to 
patients at tertiary care hospitals that deliver this specialized type of RT.  Sixth, the 
broad categorization of diagnoses and low number of hematological malignancies may 
have masked a disease-specific effect on malnutrition.  Finally, malnutrition at the end of 
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RT was evaluated using three malnutrition indicators: low weight gain velocity, 
deceleration of weight for length/height z-scores, and percent weight loss.  Data 
comparing the different criteria for the three malnutrition indicators with clinical outcomes 
after RT, such as event-free survival rates or treatment response, are needed to 
evaluate the clinical implications of nutritional status changes in this patient population.  
Despite these limitations, a major strength of this exploratory study is that it provides 
preliminary data to support the continued study of various nutrition-related short-term 
and long-term outcomes in pediatric oncology patients.  Another strength of this 
exploratory study is that it identifies a subgroup of pediatric oncology patients who are 
susceptible to malnutrition and, thus, should be closely monitored for significant 
nutritional status changes during RT (i.e., patients aged < 2 years receiving AART with 
concurrent chemotherapy).   
In conclusion, this exploratory study found that pediatric oncology patients 
younger than 2 years of age receiving AART are more likely than those who do not 
receive AART to be malnourished by the end of treatment; however, malnutrition status 
is not associated with repetitive, pre-anesthetic fasting, but with young age and 
concurrent chemotherapy.  Further research is needed to corroborate these findings and 
to explore the underlying adverse metabolic effects (e.g., depletion of hepatic glycogen 
reserves, increased protein catabolism, higher energy expenditure at rest, post-
treatment insulin resistance)(Awad et al., 2009; Awad & Lobo, 2012; Nygren, 2006). that 
may predispose or exacerbate negative nutritional status changes in younger pediatric 
oncology patients.   
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TABLE I. Patient Characteristics 
 Total AART 
Cohort 
Non-AART 
Cohort 
P-value 
Characteristic, no. (%) N = 138 (100) n = 91 (66)  n = 47 (34)  
Age at start of RT    <0.001* 
< 2 years 18 (13.0) 18 (19.8) 0  
 2 to < 5 years 49 (35.5) 47 (51.6) 2 (4.3)  
 5 years 71 (51.5) 26 (28.6) 45 (95.7)  
Gender    0.717 
Male 80 (58.0) 54 (59.3) 26 (55.3)  
Female 58 (42.0) 37 (40.7) 21 (44.7)  
Race/Ethnicity    0.148 
White  86 (62.3) 54 (59.3) 32 (68.1)  
African American 13 (9.4) 10 (11.0) 3 (6.4)  
Hispanic 24 (17.4) 19 (20.9) 5 (10.6)  
Asian 7 (5.1) 2 (2.2) 5 (10.6)  
Unknown/not reported 8 (5.8) 6 (6.6) 2 (4.3)  
Primary diagnosis    0.012* 
Hematological 
malignancies 
3 (2.2) 3 (3.3) 0  
Brain tumors 73 (52.9) 55 (60.4) 18 (38.3)  
Extracranial solid tumors 62 (44.9) 33 (36.3) 29 (61.7)  
Type of RT    0.541 
Proton 102 (73.9) 69 (75.8) 33 (70.2)  
IMRT or conventional 
XRT 
36 (26.1) 22 (24.2) 14 (29.8)  
Concurrent 
chemotherapy 
87 (63.0) 58 (63.7) 29 (61.7) 0.854 
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Clinical nutrition referrala  41 (29.7) 34 (37.4) 7 (14.9) 0.006* 
Enteral feedsb  29 (21) 23 (25.3) 6 (12.8) 0.122 
Recent or concurrent 
steroid therapyc  
25 (18.1) 18 (19.8) 7 (14.9) 0.642 
AART, anesthesia-assisted radiation therapy; non-AART, non–anesthesia-assisted radiation 
therapy; RT, radiation therapy; IMRT, intensity-modulated radiation therapy; XRT, external-
beam radiation therapy; * P < 0.05.  aReferral within 7 days before or during RT cycle; 
bEnteral feeds started 14 days before or during RT; cSteroid therapy within 3 months before 
or during RT.        
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TABLE II. Univariate Analysis of Predictors of Malnutrition at the End of Radiation Therapy 
in the AART Cohort (n = 91)a 
Variables Presence of 
malnutrition 
at end of RT 
(%) 
OR (95% CI) P 
Number of fasting days in RT cycle      
   5-day increments — 1.13 
(0.841.51) 
0.420 
Number of non-fasting days in RT cycle    
   5-day increments — 0.93 
(0.591.46) 
0.743 
Cumulative Propofol dose (mg/kg/day)b,c,d — 1.00 
(0.931.08) 
0.988 
Cumulative Kilocalories from propofol 
(Kcal/kg/day) b,c,d 
— 1.01 
(0.521.96) 
0.988 
Cumulative IVF (mL/kg/day)b,c,e — 1.06 
(0.931.21) 
0.364 
Concurrent chemotherapy      
  No (n = 33) 7 (21.2) Reference   
  Yes (n = 58) 24 (41.4) 2.62 (0.98–
7.02) 
0.055 
 Primary diagnosis      
  Non-brain tumor (n = 36) 13 (36.1) Reference  
  Brain tumor (n = 55) 18 (32.7) 0.86 
(0.362.08) 
0.739 
Age    
  < 2 years (n = 18) 10 (55.6) Reference  
   2 to < 5 years (n = 47) 13 (27.7) 0.31 
(0.100.95) 
0.040* 
   5 years (n = 26) 8 (30.8) 0.36 
(0.101.24) 
0.104 
Malnutrition at baseline    
  No (n = 74) 25 (33.8) Reference  
  Yes (n = 17) 6 (35.3) 1.07 
(0.353.23) 
0.906 
Gender    
  Male (n = 54) 18 (33.3) Reference  
  Female (n = 37) 13 (35.1) 1.08 
(0.452.61) 
0.859 
Enteral feeding    
   No (n = 68) 22 (32.4) Reference  
   Yes (n = 23) 9 (39.1) 1.34 
(0.513.58) 
0.554 
74 
 
 
 
Steroid therapy    
  No (n = 73) 26 (35.6) Reference  
  Yes (n = 18) 5 (27.8) 0.70 
(0.222.17) 
0.531 
Race/ethnicity    
  White, non-Hispanic (n = 54) 21 (38.9) Reference  
  Non-Whites (n = 37) 10 (27) 0.58 
(0.241.44) 
0.243 
Dietary supplements    
  Yes (n = 12) 2 (16.7) Reference  
  No (n =79) 29 (36.7) 2.90 
(0.5914.16) 
0.188 
Nutritional consult    
  Yes (n = 34) 9 (26.5) Reference  
  No (n = 57) 22 (38.6) 1.75 
(0.694.43) 
0.240 
Type of RT    
  IMRT or conventional XRT  
  (n = 22) 
6 (27.3) Reference  
  Proton therapy (n = 69) 25 (36.2) 1.52 
(0.534.37) 
0.442 
AART receiptf    
  Yes (n = 91) 31 (34.1)
  
3.53 
(1.359.22) 
0.010 
  No (n = 47) 6 (12.8) Reference  
OR, odds ratio; CI, confidence interval; * P < 0.05; RT, radiation therapy; IMRT, intensity-modulated 
radiation therapy; XRT, external-beam radiation therapy; aExcept where specified; bCalculated average 
weight used to calculate dose per kilogram. Average weight was calculated by averaging baseline and final 
weight, cCumulative dosing was divided by subject’s total number of radiation treatment days to adjust for 
varying lengths of radiation treatments between subjects, dn = 88, subjects who had partial AART treatment 
were excluded from analysis since they did not receive all radiation treatments under anesthesia, en = 71, 
Twenty subjects had >40% missing values for intravenous fluid administration during AART were excluded 
from analysis.   fWith both AART and non-AART cohorts combined for comparison, n = 138. 
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TABLE III. Multivariate Model of Predictors of Malnutrition at the End of Radiation 
Therapy 
Model OR (95% CI) P 
Model 1: AART cohort (n =91)   
Concurrent chemotherapy     
  No Reference   
  Yes 3.48 (1.1810.23) 0.024* 
Age   
  < 2 years Reference  
   2 to < 5 years 0.23 (0.070.77) 0.018* 
   5 years 0.26 (0.070.98) 0.047* 
Model 2: AART cohort (n = 91)   
Number of fasting days in RT cycle     
   5-day increments 1.22 (0.881.70) 0.231 
Concurrent chemotherapy     
  No Reference   
  Yes 3.97 (1.3112.08) 0.015* 
Age   
  < 2 years Reference  
   2 to < 5 years 0.22 (0.060.76) 0.017* 
   5 years 0.27 (0.071.04) 0.058 
Model 3: AART cohort (n = 91)   
Number of non-fasting days in RT cycle     
   5-day increments 1.01  (0.621.67) 0.96 
Concurrent chemotherapy     
  No Reference   
  Yes 3.49 (1.1710.43) 0.025* 
Age   
  < 2 years Reference  
   2 to < 5 years 0.23 (0.070.77) 0.018* 
   5 years 0.26 (0.070.99) 0.047* 
Model 4: AART and non-AART cohort 
(n = 138) 
  
AART     
   No Reference  
  Yes 3.078 (0.9410.04) 0.062 
Concurrent chemotherapy     
  No Reference   
  Yes 4.528 (1.6212.64) 0.004* 
Age   
  < 2 years Reference  
   2 to < 5 years 0.20 (0.060.70) 0.012* 
   5 years 0.25 (0.060.95) 0.042* 
OR, odds ratio; CI, confidence interval; * P < 0.05; RT, radiation therapy; AART, anesthesia-assisted 
radiation therapy; non-AART, non–anesthesia-assisted radiation therapy 
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APPENDIX 
Supplemental Table I. Cumulative Malnutrition Coding  Discrepancies When Indicators 
Overlapped 
Study ID Age at 
start of 
RT (yr) 
Height 
at end 
of RT 
(cm) 
Percent 
Weight loss 
from 
baseline 
(Patients > 
2 years)  
Weight for 
Length/Height z-
score difference 
(Patients < 
121.5 cm height) 
Expected 
weight gain 
percentile 
(Patients < 2 
years) 
Cumulative 
Malnutrition 
Final 
coding 
003 1.08 70.0  -0.39 NM <25% M M 
004 1.58 75.7  -0.76 NM <25% M M 
011 4.42 110.0 -0.05 M -0.51 NM  M 
016 1.42 76.6  -0.47 NM <25% M M 
025 4.08 104.0 -0.06 M -0.80 NM  M 
038 1.50 90.0  -0.33 NM <25% M M 
039 4.50 103.5 -0.04 NM -1.24 M  M 
057 1.08 74.5  -0.17 NM <25% M M 
069 4.00 101.0 -0.05 M -0.09 NM  M 
070 3.17 99.7 -0.07 M -0.97 NM  M 
071 5.67 104.0 -0.07 M -0.43 NM  M 
077 1.83 81.5  -0.63 NM 25x50% 
M 
M 
081 4.25 103.5 -0.08 M -0.99 NM  M 
095 1.50 75.0  -0.11 NM <25% M M 
098 1.83 85.0  -0.80 NM <25% M M 
104 3.50 91.0 -0.07 M -0.87 NM  M 
118 1.58 79.6  -0.23 NM <25% M M 
126 3.08 96.0 -0.06 M -0.70 NM  M 
133 3.75 114.0 -0.05 M -0.70 NM  M 
134 3.50 99.0 0.06 NM -2.02 M  M 
77 
 
 
 
138 5.50 109.0 -0.05 M -0.56 NM  M 
Yr, years; cm, centimeters; M, Malnourished as defined by malnutrition indicator used; NM, Not 
malnourished as defined by malnutrition indicator used; RT, Radiation therapy.  
 
Supplemental Table II. Radiation Therapy Treatment Regimens 
 Total AART Cohort Non-
AART 
Cohort 
 Mean, Median 
(IQR) 
Median (IQR) Median 
(IQR) 
Number of fasting days during 
RT 
15.9, 20 (0–29) 28 (20–30) 0 (0)  
Number of non-fasting days 
during RT 18.9, 13 (10–30) 
12 (913) 38 
(2942) 
Duration of RT cycle, days  35.1, 40 (29–43) 40 (29–43) 39 (29–
42) 
Number of RT treatments 24.3, 28 (20–30) 28 (20–30) 28 (20–
30) 
 
 
Supplemental Table III. Anesthetic Administration in AART Cohort 
 Mean, Median (IQR) 
Cumulative Propofol dose (mg/kg/day)a,b,c  12.57, 12.52 (8.8915.11) 
Cumulative Kilocalories from propofol 
(Kcal/kg/day) a,b,c  
1.38, 1.38 (0.981.66) 
Cumulative IVF (mL/kg/day)a,b,d 13.51, 12.97 (10.6715.72) 
AART, anesthesia-assisted radiation therapy; IVF, intravenous fluid; Kcal, Kilocalories; 
kg, kilogram; mg, milligrams; RT, radiation therapy.  aCalculated average weight used to 
calculate dose per kilogram. Average weight was calculated by averaging baseline and 
final weight, bCumulative dosing was divided by subject’s total number of radiation 
treatment days to adjust for varying lengths of radiation treatments between subjects, cn 
= 88, subjects who had partial AART treatment were excluded from analysis since they 
did not receive all radiation treatments under anesthesia, dn = 71, Twenty subjects had 
>40% missing values for intravenous fluid administration during AART were excluded 
from analysis.  
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Supplemental Table IV. Malnutrition at Baseline  
Malnutrition Indicator Total AART Cohort Non-AART Cohort 
Weight for 
length/height z-scorea,b  
19 (13.7)  15 (16.5)  4 (8.5) 
BMI for age z-scorea,c 7 (5.1) 2 (2.2) 5 (10.6) 
Cumulatived  26 (18.8) 17 (18.7) 9 (19.1) 
BMI, Body Mass Index;  az-score  –1; bn = 102; cn = 36; dOutcomes from all malnutrition 
indicators at baseline combined (Weight for length/height z-score plus BMI for age z-score).  
 
Supplemental Table V. Malnutrition at the End of Radiation Therapy 
Malnutrition 
Indicators 
Total AART Cohort Non-AART Cohort 
Low weight gain 
velocitya 
10  10  n/a 
Deceleration weight 
for length/height z-
scoreb,c 
15 12 3 
Weight lossd 25 19 6 
Cumulativee  37 (26.8) 31 (34.1) 6 (12.8) 
aPatients < 2 years of age with < 75% weight gain for gender and age, n = 18; bn = 102; 
cDeceleration z-score  1 in patients  121.5 cm in length/height; dWeight loss  5% from 
baseline weight in patient ≥ 2 years of age, n = 120; eOutcomes from all malnutrition indicators 
at the end of RT combined (Low weight gain velocity plus deceleration weight for length/height 
z-score plus weight loss); 
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Physiology, Pathophysiology, and Biochemisty for Nurse Anesthetists I, UTHealth 
School of Nursing, Houston, TX 
08/2015  “Neurocognitive Outcomes in Pediatrics After Anesthetic Exposure,” [Speaker] 
American Association of Nurse Anesthetists, 2015 Nurse Anesthesia Annual Congress, 
Salt Lake City, UT 
03/2015  “Geriatric pharmacology: A focus on postoperative cognitive dysfunction,” [Speaker] 
Texas Association of Nurse Anesthetists, 2015 Spring Meeting, San Antonio, TX 
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12/2012  “Fetal & neonatal pulmonary anatomy and physiology,” [Guest speaker] Advanced 
Anatomy, Physiology, Pathophysiology, and Biochemisty for Nurse Anesthetists I, 
UTHealth School of Nursing, Houston, TX 
09/2012   “Understanding the thromboelastogram tracing and its use in goal‐directed transfusion 
therapy,” [Poster presentation] Texas Association of Nurse Anesthetists, 2012 Fall 
Annual Convention, San Antonio, TX 
09/2012  “Mitochondrial myopathies in children,” [Student presentation] Role Practicum I, 
UTHealth School of Nursing, Houston, TX 
05/2012  “Neuro & endocrine physiology,” [Student presentation] Clinical Practicum II, UTHealth 
School of Nursing, Houston, TX 
12/2011  “Interventions to improve cost‐related health outcomes in the geriatric population 
with low‐literacy: A systematic review,” [Student presentation] Evaluation and 
Application of Research in Advanced Nursing Practice, UTHealth School of Nursing, 
Houston, TX 
11/2011  “Justification for proposed tuition increases at the UTHealth School of Nursing,” 
[Student leadership presentation] Town Hall Student Meeting, UTHealth School of 
Nursing, Houston, TX 
11/2011  “The U.S. nursing shortage: A concise update,” [Student presentation] Professional 
Aspects, UTHealth School of Nursing, Houston, TX 
2010–2011  “Student InterCouncil introduction and overview,” [Student leadership presentation] 
Undergraduate and graduate student orientations, UTHealth School of Nursing, 
Houston, TX 
09/2011  “Student orientation to SRNA blackboard pages,” [Guest speaker] Incoming nurse 
anesthesia student orientation, UTHealth School of Nursing, Houston, TX 
03/2011  “CPR and first aid training for the lay rescuer,” [Guest speaker] Seniors’ Ministry, 
Calvary Houston,  Friendswood, TX 
03/2009  “Diabetes: Symptoms, diagnosis, treatment and management,” [Guest speaker] 
Seniors’ Ministry, Calvary Houston, Friendswood, TX 
02/2009  “Overview of organ donation: From brain death to procurement” & 
“Nursing care for patients with left ventricular assist devices,” [Guest speaker] Health 
Occupations Students of America, Sam Rayburn High School Chapter, Pasadena, TX 
04/2008  “Pursuing nursing as a career,” [Guest speaker] Health Occupations Students of 
America, Sam Rayburn High School Chapter, Pasadena, TX 
Awards 
08/2013  Memorial Hermann Accelerated PhD Scholar, UTHealth School of Nursing 
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05/2013  Nurse Anesthesia Program Director’s Award, UTHealth School of Nursing 
03/2013  AANA 2013 Annual Mid‐Year Assembly Meeting Scholarship, Texas Association of 
Nurse Anesthetists  
08/2012, 08/2010  Advanced Education Nursing Traineeship Scholarship, American Association of Colleges 
of Nursing  
08/2012  AANA 2012 Annual Meeting Scholarship, Texas Association of Nurse Anesthetists  
08/2012  Dawn Gross Endowed Scholarship, UTHealth School of Nursing 
 
 
